Contraindicated. Coadministration not advised; robust cytochrome P450 enzyme inducers reduce systemic exposure to roflumilast and may reduce the therapeutic effectivenessWatch Closely (1)phenobarbital will minimize the level or impact of tofacitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Lack of, or lessened re